Estrogen receptor beta repurposes EZH2 to inhibit oncogenic NFκB signaling in triple negative breast cancer

Authors:

KGM Aspros, AW Nelson, Z Ye, Z Sun, I Chernukhin, JS Carroll, JN Ingle, MP Goetz, JR Hawse

Journal:

CANCER RESEARCH

Citation info:

80(4)

Publication date:

1st Aug 2020

Full text

DOI